Insights into the Reaction of Protein-tyrosine Phosphatase 1B: Crystal Structures for Transition State Analogs of Both Catalytic Steps

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2010 Mar 19

PMID 20236928

Citations 62

Authors

Tiago A S Brandao

Alvan C Hengge

Sean J Johnson

Affiliations

Soon will be listed here.

Abstract

Catalysis by protein-tyrosine phosphatase 1B (PTP1B) occurs through a two-step mechanism involving a phosphocysteine intermediate. We have solved crystal structures for the transition state analogs for both steps. Together with previously reported crystal structures of apo-PTP1B, the Michaelis complex of an inactive mutant, the phosphoenzyme intermediate, and the product complex, a full picture of all catalytic steps can now be depicted. The transition state analog for the first catalytic step comprises a ternary complex between the catalytic cysteine of PTP1B, vanadate, and the peptide DADEYL, a fragment of a physiological substrate. The equatorial vanadate oxygen atoms bind to the P-loop, and the apical positions are occupied by the peptide tyrosine oxygen and by the PTP1B cysteine sulfur atom. The vanadate assumes a trigonal bipyramidal geometry in both transition state analog structures, with very similar apical O-O distances, denoting similar transition states for both phosphoryl transfer steps. Detailed interactions between the flanking peptide and the enzyme are discussed.

Citing Articles

Structural and kinetic characterization of DUSP5 with a Di-phosphorylated tripeptide substrate from the ERK activation loop.

Imhoff A, Sweeney N, Bongard R, Syrlybaeva R, Gupta A, Del Carpio E Front Chem Biol. 2025; 3.

PMID: 39749114 PMC: 11694514. DOI: 10.3389/fchbi.2024.1385560.

SHP-1 Variants Broaden the Understanding of pH-Dependent Activities in Protein Tyrosine Phosphatases.

Shen R, Brownless A, Alansson N, Corbella M, Kamerlin S, Hengge A JACS Au. 2024; 4(8):2874-2885.

PMID: 39211599 PMC: 11350601. DOI: 10.1021/jacsau.4c00078.

More than two components: complexities in bacterial phosphosignaling.

Frando A, Grundner C mSystems. 2024; 9(5):e0028924.

PMID: 38591891 PMC: 11097640. DOI: 10.1128/msystems.00289-24.

Structural analysis of PTPN21 reveals a dominant-negative effect of the FERM domain on its phosphatase activity.

Chen L, Qian Z, Zheng Y, Zhang J, Sun J, Zhou C Sci Adv. 2024; 10(9):eadi7404.

PMID: 38416831 PMC: 10901363. DOI: 10.1126/sciadv.adi7404.

Allostery in Protein Tyrosine Phosphatases is Enabled by Divergent Dynamics.

Welsh C, Madan L J Chem Inf Model. 2024; 64(4):1331-1346.

PMID: 38346324 PMC: 11144062. DOI: 10.1021/acs.jcim.3c01615.

References

Zhang Y, Hollfelder F, Gordon S, Chen L, Keng Y, Wu L . Impaired transition state complementarity in the hydrolysis of O-arylphosphorothioates by protein-tyrosine phosphatases. Biochemistry. 1999; 38(37):12111-23. DOI: 10.1021/bi990836i. View

Davis I, Leaver-Fay A, Chen V, Block J, Kapral G, Wang X . MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 2007; 35(Web Server issue):W375-83. PMC: 1933162. DOI: 10.1093/nar/gkm216. View

Hengge A . Isotope effects in the study of phosphoryl and sulfuryl transfer reactions. Acc Chem Res. 2002; 35(2):105-12. DOI: 10.1021/ar000143q. View

Zalatan J, Catrina I, Mitchell R, Grzyska P, OBrien P, Herschlag D . Kinetic isotope effects for alkaline phosphatase reactions: implications for the role of active-site metal ions in catalysis. J Am Chem Soc. 2007; 129(31):9789-98. PMC: 3171187. DOI: 10.1021/ja072196+. View

Schubert H, Fauman E, Stuckey J, Dixon J, Saper M . A ligand-induced conformational change in the Yersinia protein tyrosine phosphatase. Protein Sci. 1995; 4(9):1904-13. PMC: 2143214. DOI: 10.1002/pro.5560040924. View

Pedersen A, Peters G G, Moller K, Iversen L, Kastrup J . Water-molecule network and active-site flexibility of apo protein tyrosine phosphatase 1B. Acta Crystallogr D Biol Crystallogr. 2004; 60(Pt 9):1527-34. DOI: 10.1107/S0907444904015094. View

Fauman E, Yuvaniyama C, Schubert H, Stuckey J, Saper M . The X-ray crystal structures of Yersinia tyrosine phosphatase with bound tungstate and nitrate. Mechanistic implications. J Biol Chem. 1996; 271(31):18780-8. DOI: 10.1074/jbc.271.31.18780. View

Lu Z, Dunaway-Mariano D, Allen K . The catalytic scaffold of the haloalkanoic acid dehalogenase enzyme superfamily acts as a mold for the trigonal bipyramidal transition state. Proc Natl Acad Sci U S A. 2008; 105(15):5687-92. PMC: 2311376. DOI: 10.1073/pnas.0710800105. View

Painter J, Merritt E . Optimal description of a protein structure in terms of multiple groups undergoing TLS motion. Acta Crystallogr D Biol Crystallogr. 2006; 62(Pt 4):439-50. DOI: 10.1107/S0907444906005270. View

10.

Baxter N, Olguin L, Golicnik M, Feng G, Hounslow A, Bermel W . A Trojan horse transition state analogue generated by MgF3- formation in an enzyme active site. Proc Natl Acad Sci U S A. 2006; 103(40):14732-7. PMC: 1595420. DOI: 10.1073/pnas.0604448103. View

11.

Sarmiento M, Puius Y, Vetter S, Keng Y, Wu L, Zhao Y . Structural basis of plasticity in protein tyrosine phosphatase 1B substrate recognition. Biochemistry. 2000; 39(28):8171-9. DOI: 10.1021/bi000319w. View

12.

Rye C, Baell J . Phosphate isosteres in medicinal chemistry. Curr Med Chem. 2005; 12(26):3127-41. DOI: 10.2174/092986705774933452. View

13.

Barford D, Keller J, Flint A, Tonks N . Purification and crystallization of the catalytic domain of human protein tyrosine phosphatase 1B expressed in Escherichia coli. J Mol Biol. 1994; 239(5):726-30. DOI: 10.1006/jmbi.1994.1409. View

14.

Johnson T, Ermolieff J, Jirousek M . Protein tyrosine phosphatase 1B inhibitors for diabetes. Nat Rev Drug Discov. 2002; 1(9):696-709. DOI: 10.1038/nrd895. View

15.

Phan J, Lee K, Cherry S, Tropea J, Burke Jr T, Waugh D . High-resolution structure of the Yersinia pestis protein tyrosine phosphatase YopH in complex with a phosphotyrosyl mimetic-containing hexapeptide. Biochemistry. 2003; 42(45):13113-21. DOI: 10.1021/bi030156m. View

16.

Zhang S, Zhang Z . PTP1B as a drug target: recent developments in PTP1B inhibitor discovery. Drug Discov Today. 2007; 12(9-10):373-81. DOI: 10.1016/j.drudis.2007.03.011. View

17.

Barford D, Flint A, Tonks N . Crystal structure of human protein tyrosine phosphatase 1B. Science. 1994; 263(5152):1397-404. View

18.

Jones J, Weiss P, Cleland W . Secondary 18O isotope effects for hexokinase-catalyzed phosphoryl transfer from ATP. Biochemistry. 1991; 30(15):3634-9. DOI: 10.1021/bi00229a007. View

19.

Nandan D, Reiner N . Leishmania donovani engages in regulatory interference by targeting macrophage protein tyrosine phosphatase SHP-1. Clin Immunol. 2005; 114(3):266-77. DOI: 10.1016/j.clim.2004.07.017. View

20.

Ostman A, Hellberg C, Bohmer F . Protein-tyrosine phosphatases and cancer. Nat Rev Cancer. 2006; 6(4):307-20. DOI: 10.1038/nrc1837. View